Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-06-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于所提供信息真实、准确、完整等事项的承诺函（一）
Regulatory Filings Classification · 95% confidence The document is a letter of commitment regarding the truthfulness, accuracy, and completeness of information provided in relation to a share issuance transaction for acquiring equity in another company. It is a legal assurance letter from a transaction counterparty to the listed company. The document does not contain financial statements, audit results, or detailed financial data. It is not an announcement of voting results, nor a report or presentation. It is a legal or regulatory assurance related to a transaction. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2017-06-30 Chinese
董事会关于发行股份购买资产并募集配套资金履行法定程序的完备性、合规性及提交法律文件的有效性的说明
Regulatory Filings Classification · 95% confidence The document is a statement from the board of directors of 三诺生物传感股份有限公司 regarding the completeness, compliance, and validity of legal documents submitted for a transaction involving issuance of shares to purchase assets and raise supporting funds. It discusses the legal procedures and compliance related to a major asset restructuring transaction, referencing regulatory requirements and commitments by the board and directors. The document is relatively short (1400 characters) and serves as a formal announcement or explanation rather than a full financial report or detailed transaction filing. It does not contain financial statements or detailed financial data but rather legal and procedural assurances related to the transaction. Therefore, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-06-30 Chinese
2016年度、2017年1-3月备考审阅报告
Audit Report / Information Classification · 95% confidence The document is a detailed financial report including a review report by a certified public accountant firm, consolidated financial statements such as balance sheets and income statements for the periods ending 2016 and Q1 2017, and notes to the financial statements. It mentions the review (审阅报告) of the consolidated financial statements prepared according to accounting standards, with limited assurance but not a full audit. The presence of detailed financial data, including assets, liabilities, equity, income, expenses, and notes, indicates this is a financial report rather than a mere announcement or certification. The document is not a full audit report but a review report, which is a type of audit-related report but distinct from a full annual report (10-K). The document is not a short announcement or a certification letter but a substantive financial report with review opinion. Therefore, the best fitting category is Audit Report / Information (AR).
2017-06-30 Chinese
中信证券股份有限公司关于《三诺生物传感股份有限公司关于发行股份购买资产信息公布前公司股票价格波动是否达到〈关于规范上市公司信息披露及相关各方行为的通知〉相关标准的说明》的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from CITIC Securities regarding the stock price fluctuation of SanNuo Bio-Sensing Co., Ltd. before the announcement of a share issuance for asset purchase. It references regulatory standards from the China Securities Regulatory Commission about information disclosure and stock price abnormality. The content focuses on compliance verification and stock price analysis rather than financial results, management changes, or shareholder votes. The document length is short (1339 characters) and it is a specific verification opinion, not a full report or announcement of a report. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2017-06-30 Chinese
关于符合重大资产重组及发行股份购买资产并募集配套资金条件的承诺函
Regulatory Filings Classification · 95% confidence The document is a formal commitment letter from the company and its directors, supervisors, and senior management regarding compliance with conditions for a major asset restructuring and issuance of shares to purchase assets and raise supporting funds. It references specific regulatory rules such as the "Administrative Measures for Major Asset Restructurings of Listed Companies (2016 Revision)" and the "Interim Measures for the Administration of Securities Issuance of GEM Listed Companies." The document contains no financial statements or detailed financial data but rather assurances and compliance confirmations related to the transaction. The length is 3432 characters, which is relatively short and the document is essentially a letter of commitment or certification related to a capital transaction. It is not a full report, audit, or financial statement. Therefore, it fits best as a Regulatory Filing (RNS) because it is a formal regulatory compliance document that does not fit other categories such as Capital/Financing Update (CAP) which would typically include more transactional details or financial data, nor is it a Management Report or Audit Report. The document is a compliance commitment letter related to a major asset restructuring and share issuance, thus Regulatory Filings (RNS) is the most appropriate classification.
2017-06-30 Chinese
中信证券股份有限公司对本次交易申请文件真实性、准确性和完整性的承诺书
Regulatory Filings Classification · 100% confidence The document is a short certification letter from CITIC Securities Co., Ltd. regarding the authenticity, accuracy, and completeness of transaction application documents related to a restructuring. It is signed by legal representatives and financial advisors. The document length is only 314 characters, indicating it is a brief attestation rather than a full report or detailed filing. It does not contain financial data or detailed report content but serves as a formal certification. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2017-06-30 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.